Fig. 3From: Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancerComparisons of soluble PD-L1 in patients with metastasis colorectal cancer. a sPD-L1 was significantly elevated in metastatic tumors. b Distant lymph node metastasis indicated higher level of sPD-L1. c CPS positive was associated with increased sPD-L1 concentration while no correlation was found between TPS and sPD-L1. d No correlation was found between RAS/BRAF mutation and sPD-L1 concentrationBack to article page